Stereotaxis, Inc. (STXS) Earnings Call Analysis

AMEX · Healthcare · Medical Instruments & Supplies

21/25

Growth 5 Margin 3 Expansion 5 Platform 5 Financial 3

latest quarter score

Earnings Reports

21
Stereotaxis (STXS) Q2 2026: Robotic Catheter Revenue Surges 270%, Paving Path to 2027 Cash Flow Profitability
August 12, 2026
19
STXS Q3 2025: MagicSweep Catheter Adds $300K in Two Months, Catalyzing Recurring Revenue Shift
June 16, 2026
17
STXS Q1 2026: MAGIC Catheter Ramp Targets $10M+ Quarterly Recurring Revenue Run Rate
May 13, 2026
18
STXS Q4 2025: Average Procedure Revenue Jumps 5x as Proprietary Catheter Ramp Reshapes Model
March 10, 2026
15
Stereotaxis (STXS) Q2 2025: Recurring Revenue Jumps 35% as Proprietary Catheters Gain Traction
August 08, 2025
9
Stereotaxis (STXS) Q1 2025: Recurring Revenue Surges 29% Amid Innovation and Regulatory Progress
May 12, 2025
Stereotaxis (STXS) Q4 2024: 39% Revenue Growth Highlights Strategic Transition to Scalable Robotic Platform
March 03, 2025

Browse all companies